Predictive Genetic Testing Market Size, Share, Growth Insights, and Forecast to 2031

The predictive genetic testing market is projected to reach US$ 4.20 billion by 2031 from US$ 1.42 billion in 2024 and to register a CAGR of 17.1% during 2025–2031.  

Predictive Genetic Testing Market Analysis

Key factors driving market growth include the rising prevalence of genetic diseases, increasing awareness and acceptance of personalized medicines, and surging preference for direct-to-consumer (DTC) genetic testing. Increasing acceptance and funding for rare disease and carrier screening initiatives are likely to create ample opportunities for the predictive genetic testing market in the coming years.

Predictive Genetic Testing Market Overview

Predictive genetic testing allows the early recognition of the patient's risk of cancer, cardiovascular diseases, or neurodegenerative disorders, usually even before the appearance of symptoms. Thanks to advancements in sequencing technology, AI-based interpretation, and bioinformatics, such tests have become a key component of preventive care and personalized treatment. North America and Europe are the leading adopters due to their robust healthcare infrastructure. In contrast, APAC is unfolding quickly, driven by increasing healthcare expenditure and greater access to genomics.

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Predictive Genetic Testing Market: Strategic Insights

Predictive Genetic Testing Market Drivers and Opportunities

Market Drivers:

• Rising Prevalence of Genetic Diseases: The global rise in the number of inherited and chronic genetic disorders pushes the demand for predictive genetic testing, which makes it possible to detect the condition early, carry out prevention, and improve the management of people who are at high risk.
• Increasing Awareness and Acceptance of Personalized Medicines: Understanding about precision medicine leads to the use of predictive genetic testing, which enables healthcare providers to tailor prevention, monitoring, and treatment strategies according to a patient's genetic profile.
• Growing Preference for Direct-To-Consumer (DTC) Genetic Testing: Consumers' desire to gain a better understanding of their health while enjoying the convenience of self-testing without intermediaries has empowered them to access risk information and make informed decisions about their lifestyle and healthcare.

Market Opportunities:

• Untapped Emerging Markets in Developing Countries: With the expansion of healthcare infrastructure and rising awareness, regions in the developing world offer a tremendous potential for predictive genetic testing to be the next frontier in healthcare. These areas can be reached with the help of less expensive and portable tests, creating demand for genetic screening, which has been previously neglected among these populations.
• Increasing Acceptance and Funding for Rare Disease and Carrier Screening Initiatives: An increase in government and private investments in research into rare diseases and carrier screening programs is a key factor driving the implementation of predictive genetic testing, thereby enabling the identification of diseases at an early stage and facilitating better therapy management.
• Expansion of At-Home Testing Kits: The invention and subsequent rise in the use of home diagnostic kits for predictive genetic testing are the primary ways through which people are provided with convenient and accessible options, thus leading to the adoption of such tests on a broader scale and allowing individuals to take charge of their hereditary risk factors right in their ​‍​‌‍​‍‌​‍​‌‍​‍‌homes.

Predictive Genetic Testing Market Report Segmentation Analysis

The predictive genetic testing market is segmented into various categories to provide a clearer understanding of its operations, growth potential, and current trends. Below is the standard segmentation approach used in industry reports:

By Type:

• Predispositional Testing: It identifies genetically inherited risk factors that may lead to diseases over time, allowing individuals to take necessary precautions and follow a personalized medical care plan.
• Presymptomatic Testing: It is a test that detects the absence of symptoms of a specific illness in a person who genetically carries disease-causing mutations. Thus, it can be used for intervention, continuous check-ups, and making better-informed medical and lifestyle decisions.

By Disease:

• Cancer: Predictive​‍​‌‍​‍‌​‍​‌‍​‍‌ genetic testing locates mutations that are passed down from the parents and increase the risk of cancer. In this way, methods for early detection, prevention, and personalized treatment become available.
• Cardiovascular Diseases: Identifies genetic predisposition that may lead to heart diseases, thus giving a chance for early intervention, changing lifestyle habits, and risk control to avert serious cardiovascular incidents.
• Metabolic Diseases: It evaluates the hereditary risks of diseases such as diabetes and obesity, thus providing the preventive care, diet control, and personalized healthcare that are necessary.
• Other Diseases: Diseases affecting the brain, the immune system, and rare genetic disorders are included, providing the opportunity for early identification, examination, and initiation of management to enhance patients’ prognosis.

By End User:

• Hospital-Based Laboratories
• Diagnostic Laboratories
• Other End Users:

By Geography:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Predictive Genetic Testing Market Regional Insights

The regional trends and factors influencing the Predictive Genetic Testing Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Predictive Genetic Testing Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Predictive Genetic Testing Market Report Scope

Predictive Genetic Testing Market Players Density: Understanding Its Impact on Business Dynamics

The Predictive Genetic Testing Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Predictive Genetic Testing Market Share Analysis by Geography

North America is expected to hold a significant market share. The rising prevalence of genetic diseases, increasing awareness and acceptance of personalized medicines, and growing preference for direct-to-consumer (DTC) genetic testing drive the market growth. Asia Pacific is expected to grow the fastest in the next few years. Emerging markets in South and Central America, the Middle East, and Africa also offer untapped opportunities for predictive genetic testing to expand.

The growth rates of the predictive genetic testing market vary by region, influenced by the recommendations of regulatory agencies and medical guidelines for predictive genetic testing. Below is a summary of market share and trends by region:

1. North America

• Market Share: Holds a significant portion of the global market
• Key Drivers: An advanced healthcare infrastructure, robust research and development, and high awareness of personalized medicine have facilitated the primary adoption of predictive genetic testing.

• Trends: Developmental advancements and genetic testing practices

2. Europe

• Market Share: Substantial share due to the increasing prevalence of pain conditions
• Key Drivers: Government-funded projects, awareness activities, and an emphasis on prevention are facilitating the complete utilization of predictive genetic testing in healthcare systems.
• Trends: Regulatory influence on market structure

3. Asia Pacific

• Market Share: Fastest-growing region with rising market shares every year
• Key Drivers: It is a rapidly evolving area, characterized by a notable increase in healthcare investments, the establishment of genetic testing facilities, and a growing awareness of personalized and preventive medicine.

• Trends: Innovations in genetic testing services

4. South and Central America

• Market Share: Growing market with steady progress
• Key Drivers: The expansion of genetic testing services, driven by increased access to healthcare, heightened awareness, and the implementation of modern diagnostic technologies, presents a region with growth potential.

• Trends: Technological developments in genetic testing

5. Middle East and Africa

• Market Share: Small market growing at a rapid pace
• Key Drivers: The development of the market is a result of the modernization of the healthcare sector, government support for genetic testing, and increasing incidences of hereditary and lifestyle diseases.
• Trends: Growth in the acceptance and awareness regarding genetic testing

Predictive Genetic Testing Market Players Density: Understanding Its Impact on Business Dynamics

High Market Density and Competition

Competition is intense due to established players such as Eurofins Scientific SE, Illumina Inc., and F. Hoffmann-La Roche Ltd. Regional and niche providers, including Exact Sciences Corp. and GeneDx, LLC, add to the competitive landscape across different regions.

This high level of competition urges companies to stand out by offering:

• Advanced products
• Value-added services such as customization and sustainable solutions
• Competitive pricing models
• Compliance with regulatory guidelines

Opportunities and Strategic Moves

• Companies are investing in research and development, driving innovation in detection technologies. These investments improve the sensitivity and specificity, addressing specific eye health issues in different regions.
• Manufacturers will likely focus on local production to cut costs and strengthen supply chains, especially in high-volume markets such as India.

Other companies analyzed during the course of research:

1. Guardant Health
2. BGI Genomics
3. Bio-Rad Laboratories
4. ARUP Laboratories
5. Invitae Corporation
6. Ancestry Genomics Inc
7. Progenesis
8. Fulgent Genetics, Inc
9. SIVOTEC BioInformatics LLC
10. Gene By Gene Ltd

Predictive Genetic Testing Market News and Recent Developments

• Seonix Bio launches SightScore testing service for primary open-angle glaucoma. Seonix Bio announced the commercial launch of SightScore, a clinical polygenic risk score testing service for primary open-angle glaucoma (POAG).
• Proteomics International Laboratories launches PromarkerD predictive test for diabetic kidney disease. Proteomics International Laboratories officially launched its unique PromarkerD predictive test for diabetic kidney disease in Australia. PromarkerD is a clinically validated blood test that helps predict the risk of developing chronic diabetic kidney disease (DKD) in patients with type 2 diabetes up to four years before clinical symptoms appear.

Predictive Genetic Testing Market Report Coverage and Deliverables

The "Predictive Genetic Testing Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

• Predictive genetic testing market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Predictive genetic testing market trends, and market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST and SWOT analysis
• Predictive genetic testing market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the predictive genetic testing market
• Detailed company profiles